Which neonatal consideration should be monitored postpartum when maternal thyroid disease is managed during pregnancy?

• A. Neonatal status is unrelated to maternal thyroid status.
• B. Neonatal hypothyroidism screening is unnecessary if maternal thyroid disease is controlled.
• C. Neonatal status should be monitored postpartum for thyroid function; monitor for neonatal hypothyroidism; arrange appropriate follow-up testing as needed.
• D. Neonatal hearing screening is the only test needed.

Answer: (C)

Neonatal thyroid status must be monitored after birth because maternal thyroid disease, even when well-controlled during pregnancy, doesn’t guarantee that the newborn’s thyroid function is normal. The baby’s thyroid axis can be affected independently, and congenital hypothyroidism can be present regardless of maternal treatment. Early detection and treatment of neonatal hypothyroidism are crucial to prevent neurodevelopmental problems, so newborn thyroid function testing (typically TSH and sometimes free T4) should be arranged and followed as needed.

This approach is more appropriate than assuming the newborn’s thyroid status is unrelated to maternal thyroid health, or relying solely on screening for non-thyroid issues like hearing. Even if maternal thyroid disease is controlled, monitoring postpartum for thyroid function and scheduling follow-up testing ensures any neonatal thyroid concerns are identified promptly.